HENRY VANPALA: Open Payments
NPI 1710241658 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,990 in 238 payments from 34 companies in 2025. Trend: 2023 $6,233 · 2024 $6,118 · 2025 $4,990
Food & beverage: $4,981Education: $9
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 25 | $582 |
| ABBVIE INC. | 22 | $372 |
| Amgen Inc. | 20 | $363 |
| PFIZER INC. | 15 | $310 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 24 | $283 |
| E.R. Squibb & Sons, L.L.C. | 9 | $271 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $230 |
| Novo Nordisk Inc | 16 | $224 |
| Janssen Pharmaceuticals, Inc | 9 | $224 |
| Lundbeck LLC | 7 | $196 |
Products named: REXULTI, XIFAXAN, Auvelity, COBENFY, Symbravo, Kerendia, SPRAVATO, REPATHA.
Industry payments across NC — which companies pay providers there.
